Iovance Biotherapeutics Inc. Common Stock vs Life Time Group Holdings Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B), while Life Time Group Holdings Inc. Common Stock trades at $40.53 (market cap $9.00B). The key difference: Life Time Group Holdings Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Life Time Group Holdings Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Life Time Group Holdings Inc. Common Stock for 1 Days on average.
| IOVA | LTH | |
|---|---|---|
Market Cap | $6.04B | $9.00B |
Volume | 14,805,993 | 2,696,923 |
Sector | Health | Consumer Cyclical |
52-Week High | $14.82 | $45.73 |
52-Week Low | $1.81 | $24.59 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $13.05B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Life Time operates fitness and lifestyle centers that offer gyms, classes, sports facilities, and wellness services.
Read more on LTH →